Doctor pleads guilty in death of 'Friends' star Matthew Perry
Updates with doctor pleading guilty paragraphs 1-2
By Lisa Richwine
LOS ANGELES, Oct 2 (Reuters) -One of two California doctors who were among the five people charged in the overdose death of "Friends" star Matthew Perry pleaded guilty on Wednesday to a charge of illegally distributing the drug ketamine.
Dr. Mark Chavez entered the plea during an appearance in U.S. District Court in Los Angeles. At sentencing, he could face up to 10 years in prison.
Another physician charged in the case, Dr. Salvador Plasencia, has pleaded not guilty, as has co-defendant Jasveen Sangha, who authorities said was an illicit supplier of the drug and was known as the "ketamine queen." The pair are scheduled to go on trial in March.
Perry's live-in personal assistant, Kenneth Iwamasa, who admitted to injecting Perry, and the alleged middleman who said he obtained ketamine from Sangha, have already pleaded guilty to charges they faced.
Authorities said Plasencia purchased ketamine from Chavez, and in text messages to Chavez discussing the amount to charge Perry for the drug wrote: "I wonder how much this moron will pay."
Plasencia administered ketamine to Perry and supplied vials that were injected by the assistant, according to court documents.
Perry died at age 54 in October 2023 from "acute effects" of ketamine and other factors that caused him to lose consciousness and drown in his hot tub, according to a December 2023 autopsy report.
The actor had publicly acknowledged decades of substance abuse, including during the years he starred as Chandler Bing on the hit 1990s television sitcom "Friends."
Matt Binninger, Chavez's attorney, told reporters in August that his client was "doing everything in his power to cooperate, to help in this situation."
"He’s incredibly remorseful," Binninger said.
The lawyer added that Chavez's regret stemmed not from Perry's celebrity but from the fact that "someone who was trying to seek treatment died."
Reporting by Lisa Richwine
Editing by Bill Berkrot
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
